Sedation - Pipeline Review, H2 2018 Featuring Drawbridge Pharmaceuticals, Jiangsu Hengrui Medicine, Jiangsu Nhwa Pharmaceutical, Paion, Primex Pharmaceuticals & Therakind - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Sedation - Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Sedation - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Sedation (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III and Preclinical stages are 1, 4 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Sedation (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:Introduction Report Coverage Sedation - Overview Sedation - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Sedation - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Sedation - Companies Involved in Therapeutics Development Drawbridge Pharmaceuticals Pty Ltd Jiangsu Hengrui Medicine Co Ltd Jiangsu Nhwa Pharmaceutical Corp Ltd Paion AG Primex Pharmaceuticals Oy Therakind Ltd For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/8335pj/sedation?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180925006228/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Anesthetic Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/25/2018 05:49 PM/DISC: 09/25/2018 05:49 PM